Autoimmune Hepatitis in the Liver Transplant Graft

Overview

Journal Clin Liver Dis

Specialty Gastroenterology

Date 2017 Apr 3

PMID 28364820

Citations 4

Authors

Eliza W Beal

Sylvester M Black

Anthony Michaels

Affiliations

Soon will be listed here.

Abstract

Recurrent autoimmune hepatitis (AIH) and de novo AIH are 2 important causes of late graft failure after liver transplantation (LT). Recurrent AIH occurs in patients who undergo LT for AIH. De novo AIH occurs in patients who are transplanted for etiologies other than AIH. Although typically treated with standard treatment for AIH, including corticosteroids and azathioprine, both recurrent and de novo AIH may progress to end-stage liver disease requiring retransplantation.

Citing Articles

Differential IgG4-Producing Plasma Cell Infiltration in Non- and Post-Transplant Plasma Cell Hepatitis.

Horwich B, Liang T, Dodge J, Chopra S, Kahn J, Saito T Transpl Int. 2022; 35:10182.

PMID: 35368647 PMC: 8971201. DOI: 10.3389/ti.2022.10182.

HLA-DR Mismatch and Black Race Are Associated With Recurrent Autoimmune Hepatitis After Liver Transplantation.

McCabe M, Rush N, Lammert C, Patidar K, Nephew L, Saxena R Transplant Direct. 2021; 7(7):e714.

PMID: 34131586 PMC: 8196096. DOI: 10.1097/TXD.0000000000001160.

Single-Center North American Experience of Liver Transplantation in Autoimmune Hepatitis: Infrequent Indication but Good Outcomes for Patients.

de Quadros Onofrio F, Neong E, Adebayo D, Kollmann D, Adeyi O, Fischer S J Can Assoc Gastroenterol. 2021; 4(3):137-144.

PMID: 34056531 PMC: 8158643. DOI: 10.1093/jcag/gwaa022.

Autoimmune Hepatitis-Immunologically Triggered Liver Pathogenesis-Diagnostic and Therapeutic Strategies.

Sucher E, Sucher R, Gradistanac T, Brandacher G, Schneeberger S, Berg T J Immunol Res. 2019; 2019:9437043.

PMID: 31886312 PMC: 6899271. DOI: 10.1155/2019/9437043.

References

Sakai H, Urasawa K, Oyama N, Kitabatake A . Successful covering of a hepatic artery aneurysm with a coronary stent graft. Cardiovasc Intervent Radiol. 2004; 27(3):274-7. DOI: 10.1007/s00270-003-4030-x. View

Aguilera I, Sousa J, Gavilan F, Bernardos A, Wichmann I, Nunez-Roldan A . Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation. Transplant Proc. 2006; 37(9):3968-9. DOI: 10.1016/j.transproceed.2005.10.042. View

Duclos-Vallee J, Sebagh M, Rifai K, Johanet C, Ballot E, Guettier C . A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence. Gut. 2003; 52(6):893-7. PMC: 1773675. DOI: 10.1136/gut.52.6.893. View

Salcedo M, Rodriguez-Mahou M, Rodriguez-Sainz C, Rincon D, Alvarez E, Vicario J . Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation. Liver Transpl. 2009; 15(5):530-9. DOI: 10.1002/lt.21721. View

Demetris A, Adeyi O, Bellamy C, Clouston A, Charlotte F, Czaja A . Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006; 44(2):489-501. DOI: 10.1002/hep.21280. View

Sprenger R, Schlagenhaufer R, Kerb R, Bruhn C, Brockmoller J, Roots I . Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmacogenetics. 2000; 10(6):557-65. DOI: 10.1097/00008571-200008000-00009. View

Birnbaum A, Benkov K, Pittman N, Rosh J, LeLeiko N . Recurrence of autoimmune hepatitis in children after liver transplantation. J Pediatr Gastroenterol Nutr. 1997; 25(1):20-5. DOI: 10.1097/00005176-199707000-00003. View

Ratziu V, Samuel D, Sebagh M, Farges O, Saliba F, Ichai P . Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease. J Hepatol. 1999; 30(1):131-41. DOI: 10.1016/s0168-8278(99)80017-8. View

Alvarez F, Berg P, Bianchi F, Bianchi L, Burroughs A, Cancado E . International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31(5):929-38. DOI: 10.1016/s0168-8278(99)80297-9. View

10.

ISHAK K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F . Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22(6):696-9. DOI: 10.1016/0168-8278(95)80226-6. View

11.

Manns M, Czaja A, Gorham J, Krawitt E, Mieli-Vergani G, Vergani D . Diagnosis and management of autoimmune hepatitis. Hepatology. 2010; 51(6):2193-213. DOI: 10.1002/hep.23584. View

12.

Aguilera I, Martinez-Bravo M, Sousa J, Pozo-Borrego A, Nunez-Roldan A . IgG subclass profile among anti-Glutathione S-transferase T1 antibodies in post-transplant de novo immune hepatitis. Clin Transplant. 2015; 30(3):210-7. DOI: 10.1111/ctr.12675. View

13.

Czaja A, CARPENTER H, Roberts S, Charlton M, Porayko M, Rosen C . Recurrent autoimmune hepatitis after orthotopic liver transplantation. Liver Transpl. 2001; 7(4):302-10. DOI: 10.1053/jlts.2001.21449. View

14.

Mendes F, Couto C, Levy C . Recurrent and de novo autoimmune liver diseases. Clin Liver Dis. 2011; 15(4):859-78. DOI: 10.1016/j.cld.2011.08.008. View

15.

Khalaf H, Mourad W, El-Sheikh Y, Abdo A, Helmy A, Medhat Y . Liver transplantation for autoimmune hepatitis: a single-center experience. Transplant Proc. 2007; 39(4):1166-70. DOI: 10.1016/j.transproceed.2007.02.030. View

16.

Hernandez H, Kovarik P, Whitington P, Alonso E . Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr. 2001; 32(2):131-6. DOI: 10.1097/00005176-200102000-00007. View

17.

Lodato F, Azzaroli F, Tame M, Di Girolamo M, Buonfiglioli F, Mazzella N . G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence. World J Gastroenterol. 2009; 15(43):5449-54. PMC: 2778101. DOI: 10.3748/wjg.15.5449. View

18.

Andries S, Casamayou L, Sempoux C, Burlet M, Reding R, Bernard Otte J . Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation. 2001; 72(2):267-72. DOI: 10.1097/00007890-200107270-00018. View

19.

Jones D, James O, Portmann B, Burt A, Williams R, Hudson M . Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology. 1999; 30(1):53-7. DOI: 10.1002/hep.510300103. View

20.

Krishnamoorthy T, Miezynska-Kurtycz J, Hodson J, Gunson B, Neuberger J, Milkiewicz P . Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease. Liver Transpl. 2015; 22(1):34-41. DOI: 10.1002/lt.24323. View